https://www.globenewswire.com/news-release/2025/03/04/3036951/0/en/Strong-Proof-of-Concept-Data-from-Phase-2-Trial-of-PDE10A-Inhibitor-CPL-36-a-Novel-Once-Daily-Treatment-of-Levodopa-Induced-Dyskinesia-in-Parkinson-s-Disease.html
Strong Proof-of-Concept Data from Phase 2 Trial of PDE10A
Statistically significant improvement in primary endpoint (UDysRS total scale) at Week 4 and positive benefit in the key secondary endpoint (UDysRS...
proof of conceptphase 2 trialstrongdatapde10a
https://www.rcsb.org/structure/6KO1
RCSB PDB - 6KO1: The crystal structue of PDE10A complexed with 2d
The crystal structue of PDE10A complexed with 2d
rcsb pdbthe crystal
https://finviz.com/news/341604/axsome-therapeutics-acquires-selective-pde10a-inhibitor-balipodect-for-the-treatment-of-schizophrenia-and-other-neuropsychiatric-conditions
Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of...
Stock screener for investors and traders, financial visualizations.
pde10a inhibitorfor thetherapeuticsacquiresselective